James R. Ravitz - McDermott Will & Emery

Overview


James (Jamie) Ravitz works alongside clients across the entire spectrum of life sciences and healthcare law, including regulatory counsel, compliance, and investigations and government enforcement. He is particularly focused on Food and Drug Administration (FDA) regulatory counseling. Jamie works in partnership with companies and investors across the complete ecosystem of FDA-regulated products—drugs, devices, health technologies, biologics, food, cosmetics and cannabis— to help them achieve their business goals.

Jamie works with manufacturers and distributors of FDA-regulated products, with deep experience on novel drugs, biologics and cutting-edge products, from the product concept stage through to post-market and product marketing to facilitate market success and reduce enforcement risk. Jamie is a valuable addition to healthcare and life sciences transaction matters, assisting clients with FDA-related due diligence to maximize value and minimize risk and roadblocks during the transaction.

Show More

Results


  • Represented drug manufacturer in acquisition of approved drug from international pharmaceutical company*
  • Advised leading non-profit in regulatory matters involving an experimental psychotherapeutic drug product application and post-market commercialization*
  • Secured Regenerative Medicine Advanced Therapy Designations for novel human-derived regenerative medicine biologics*

Show More

Recognitions


  • Chambers USA
  • U.S. News & World Report – Best Lawyers
  • LMG Life Sciences, Leading Lawyer, Practitioner, FDA: Pharmaceutical, 2023

Community


  • BNA, Inc. – Medical Device Law and Industry, Member, Editorial Advisory Board
  • Medical Product Outsourcing, Member, Editorial Advisory Board
  • FDAnews Devices and Diagnostics Newsletter, Member, Editorial Advisory Board

Credentials


Education
Boston University School of Law, JD, 1998
Brandeis University, BA, 1993

Admissions
District of Columbia
Illinois